A901 Communication Manager Application, used in conjunction with the A710 Clinician Programmer application.. — FDA record Z-2226-2023

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jun 21, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
A901 Communication Manager Application, used in conjunction with the A710 Clinician Programmer application..
Reason
When an update to the A710 Clinician Programmer software application for the Intellis Neurostimulation System was released, the corresponding version of the A901 Communication Manager software application was not available for download.
Classification
Class II
Recalling firm
Medtronic Neuromodulation
Quantity
2 clinician tablets
Agency-reported status
Ongoing
Source record identifier
Z-2226-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilitySerial numbers NPL3011706 and NPL3016791, UDI-DI 643169738058.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

International distribution to the countries of Israel and Serbia.

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Report date
Aug 2, 2023
Recall initiation date
Jun 21, 2023
Center classification date
Jul 21, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records